BackTNF Pharmaceuticals Overview

TNF Pharmaceuticals Other Current Assets

Track TNF Pharmaceuticals's other current assets ($710K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$714121.00
↓ 20.51% YoYΔ $-184203.00 vs prior year quarter

Peer average

Loading

TNF Pharmaceuticals Other Current Assets History

Loading

TNF Pharmaceuticals vs. peers: Other Current Assets Comparison

Loading

TNF Pharmaceuticals Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TNF Pharmaceuticals (TNFA) FAQ

The latest other current assets for TNFA is $710K as of March 2026. That compares with $900K in the prior-year period — down 20.5% year over year. Investors often review this figure alongside TNF Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, TNFA's other current assets moved from $900K to $710K — a 20.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TNF Pharmaceuticals's operating scale or balance-sheet position.

A other current assets figure of $710K for TNFA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TNFA's other current assets ($710K), review year-over-year change from $900K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.